Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 44 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Dupilumab versus mepolizumab for chronic rhinosinusitis with nasal polyposis: an indirect treatment comparison.
Hopkins C, Han JK, Fokkens W, Wagenmann M, Guyot P, Khan AH, Nash S, Wang Z, Xu Y, Msihid J, Neupane B, Nag A, Bachert C
J Allergy Clin Immunol Pract, S2213-2198(24)00941-3, 24 Sep 2024
Cited by: 0 articles | PMID: 39326524
Add to export list
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab.
Bachert C, Khan AH, Hopkins C, Han JK, Fokkens WJ, Mannent LP, Msihid J, Borsos K, Kamat S, Nash S, Sacks H, Rowe PJ, Deniz Y, Jacob-Nara JA
Ann Allergy Asthma Immunol, S1081-1206(24)01535-7, 28 Sep 2024
Cited by: 0 articles | PMID: 39343385
Add to export list
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.
Bachert C, Khan AH, Fokkens WJ, Hopkins C, Gevaert P, Han JK, Hellings PW, Lee SE, Msihid J, Nash S, Sacks H, Jacob-Nara JA, Deniz Y, Rowe PJ
J Allergy Clin Immunol, S0091-6749(24)00820-0, 14 Aug 2024
Cited by: 0 articles | PMID: 39151476
Add to export list
Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials.
Kwatra SG, Yosipovitch G, Kim B, Stander S, Rhoten S, Ivanescu C, Haeusler N, Brookes E, Msihid J, Makhija M, Bansal A, Thomas RB, Bahloul D
JAMA Dermatol, 160(8):813-821, 01 Aug 2024
Cited by: 0 articles | PMID: 38865146
Add to export list
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension.
Röth A, Broome CM, Barcellini W, Jilma B, Hill QA, Cella D, Anderson Tvedt TH, Yamaguchi M, Murakhovskaya I, Lee M, Shafer F, Wardęcki M, Jayawardene D, Yoo R, Msihid J, Weitz IC
EClinicalMedicine, 74:102732, 18 Jul 2024
Cited by: 0 articles | PMID: 39114274 | PMCID: PMC11304688
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial.
Rhee CK, Park JW, Park HW, Noh H, Msihid J, Cho YS
Allergy Asthma Immunol Res, 16(4):372-386, 01 Jul 2024
Cited by: 0 articles | PMID: 39155737 | PMCID: PMC11331194
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy of avalglucosidase alfa on forced vital capacity percent predicted in treatment-naïve patients with late-onset Pompe disease: A pooled analysis of clinical trials.
Mozaffar T, Riou França L, Msihid J, Shukla P, Proskorovsky I, Zhou T, Periquet M, An Haack K, Pollissard L, Straub V
Mol Genet Metab Rep, 40:101109, 26 Jun 2024
Cited by: 0 articles | PMID: 39035044 | PMCID: PMC11259910
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
Bachert C, Gevaert P, Lipworth B, Mustafa SS, Lane AP, Mullol J, Rowe P, Deniz Y, Kamat S, Khan AH, Jacob-Nara J, Siddiqui S, Ruddy M, Laws E, Msihid J, Harel S, Jagerschmidt A, Amin N, Mannent L, Rout R
Allergy, 79(10):2858-2861, 08 Jun 2024
Cited by: 0 articles | PMID: 38850227
Add to export list
Natural history of acid sphingomyelinase deficiency among European patients during childhood and adolescence: A retrospective observational study.
Mengel E, Scarpa M, Guffon N, Jones SA, Goriya V, Msihid J, Dyevre V, Rodriguez C, Gasparic M, Nalysnyk L, Laredo F, Pulikottil-Jacob R
Eur J Med Genet, 70:104954, 08 Jun 2024
Cited by: 0 articles | PMID: 38852770
Add to export list
Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis.
Kwatra SG, Yosipovitch G, Ständer S, Guillemin I, Msihid J, Bansal A, Makhija M, Wiggins S, Zahn J, Thomas RB, Bahloul D
J Eur Acad Dermatol Venereol, 38(10):1965-1972, 24 May 2024
Cited by: 0 articles | PMID: 38785405
Add to export list
Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis.
Zeidler C, Stander S, Rhoten S, Wratten S, Zhang D, Msihid J, Brookes E, Thomas R, Bahloul D
J Eur Acad Dermatol Venereol, 38(10):1954-1964, 02 Apr 2024
Cited by: 0 articles | PMID: 38563058
Add to export list
Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis.
Stander S, Kim BS, Guillemin I, Rhoten S, Wratten S, Brookes E, O'Malley JT, Bansal A, Msihid J, Thomas R, Bahloul D
J Eur Acad Dermatol Venereol, 38(7):1401-1409, 08 Feb 2024
Cited by: 0 articles | PMID: 38329222
Add to export list
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
Hopkins C, Mullol J, Khan AH, Lee SE, Wagenmann M, Hellings P, Fokkens W, Msihid J, Nair R, Kamat S, Nash S, Radwan A, Jacob-Nara JA, Deniz Y, Rowe PJ
Otolaryngol Head Neck Surg, 170(4):1173-1182, 29 Dec 2023
Cited by: 0 articles | PMID: 38156522
Add to export list
Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial.
Toscano A, Pollissard L, Msihid J, van der Beek N, Kishnani PS, Dimachkie MM, Berger KI, DasMahapatra P, Thibault N, Hamed A, Zhou T, Haack KA, Schoser B
Mol Genet Metab, 141(2):108121, 27 Dec 2023
Cited by: 2 articles | PMID: 38184428
Add to export list
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Fiocchi AG, Phipatanakul W, Zeiger RS, Durrani SR, Cole J, Msihid J, Gall R, Jacob-Nara JA, Deniz Y, Rowe PJ, Lederer DJ, Hardin M, Zhang Y, Khan AH
Eur Respir J, 62(5):2300558, 02 Nov 2023
Cited by: 4 articles | PMID: 37734856 | PMCID: PMC10620476
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
Maspero JF, Shafazand S, Cole J, Pavord ID, Busse WW, Msihid J, Gall R, Soler X, Radwan A, Khan AH, de Prado Gómez L, Jacob-Nara JA
Respir Med, 218:107344, 01 Sep 2023
Cited by: 1 article | PMID: 37659435
Add to export list
P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY
Röth A, Broome C, Barcellini W, Jilma B, Hill Q, Cella D, Tvedt T, Yamaguchi M, Murakhovskaya I, Lee M, Shafer F, Wardęcki M, Jayawardene D, Yoo R, Msihid J, Weitz I
Hemasphere, 7(suppl ), 01 Aug 2023
Cited by: 0 articles | PMCID: PMC10430149
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
Maspero JF, Khan AH, Philpott C, Hellings PW, Hopkins C, Wagenmann M, Siddiqui S, Msihid J, Nash S, Chuang CC, Kamat S, Rowe PJ, Deniz Y, Jacob-Nara JA
J Asthma Allergy, 16:323-332, 29 Mar 2023
Cited by: 4 articles | PMID: 37016622 | PMCID: PMC10066887
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps.
Gevaert P, Lee SE, Settipane RA, Wagenmann M, Msihid J, Siddiqui S, Nash S, Jacob-Nara JA, Khan AH, Kamat S, Chuang CC
Clin Transl Immunology, 12(1):e1433, 27 Jan 2023
Cited by: 3 articles | PMID: 36721661 | PMCID: PMC9881398
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study.
Maspero JF, Cardona G, Schonffeldt P, Tolcachier A, González-Diaz SN, Yañez A, Galvao CE, Msihid J, Gall R, Siddiqui S, Rowe PJ, Deniz Y, Jacob-Nara JA, Djandji M
J Asthma, 60(5):981-990, 17 Oct 2022
Cited by: 1 article | PMID: 36066123
Add to export list
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.
Brusselle G, Quirce S, Papi A, Kuna P, Chipps BE, Hanania NA, Blaiss M, Msihid J, Jacob-Nara JA, Deniz Y, Rowe PJ, Gall R, Ortiz B, Djandji M, Radwan A
J Allergy Clin Immunol Pract, 11(3):873-884.e11, 23 Dec 2022
Cited by: 5 articles | PMID: 36572184
Add to export list
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Tohda Y, Nakamura Y, Fujisawa T, Ebisawa M, Msihid J, Djandji M, Ortiz B, Jacob-Nara JA, Deniz Y, Rowe PJ, Ishida M, Arima K
Allergol Int, 72(1):89-99, 13 Sep 2022
Cited by: 3 articles | PMID: 36114102
Add to export list
P1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST-HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS
Röth A, Karaouni A, Msihid J, Hemim I, Joly F, Shafer F, Sourdille T, Hill Q
Hemasphere, 6(suppl ), 01 Jun 2022
Cited by: 0 articles | PMCID: PMC9430638
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study.
Hopkins C, Buchheit KM, Heffler E, Cohen NA, Olze H, Khan AH, Msihid J, Siddiqui S, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y
J Asthma Allergy, 15:767-773, 07 Jun 2022
Cited by: 4 articles | PMID: 35698581 | PMCID: PMC9188334
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Lee SE, Hopkins C, Mullol J, Msihid J, Guillemin I, Amin N, Mannent LP, Li Y, Siddiqui S, Chuang CC, Kamat S, Khan AH
Allergy, 77(7):2211-2221, 01 Feb 2022
Cited by: 12 articles | PMID: 35034364 | PMCID: PMC9305228
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 44 results

1 2

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding